维普中文期刊产品整合服务

Dab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling

查看全文 作  者:Lei [1]Song;Yue [2]Gu;Jing [2]Jie;Xiaoxue [2]Bai;Ying [2]Yang;Chaoying [2]Liu;Qun [1]Liu 高影响力作者 机构地区:[1]Department of Neurology,Norman Bethune First Hospital of Jilin University;[2]Department of Respiratory Medicine,Norman Bethune First Hospital of Jilin University高影响力机构 出  处:《Neural Regeneration Research》索引2014年第9卷第1期,共10页高影响力期刊 摘  要:Transforming growth factor-beta(TGF-β)type II receptor(TβRII)levels are extremely low in the brain tissue of patients with Alzheimer’s disease.This receptor inhibits TGF-β1/SMAD signaling and thereby aggravates amyolid-beta deposition and neuronal injury.Dab2,a specific adapter protein,protects TβRII from degradation and ensures the effective conduction of TGF-β1/SMAD signaling.In this study,we used an adenoviral vector to overexpress the Dab2 gene in the mouse hippocampus and investigated the regulatory effect of Dab2 protein on TGF-β1/SMAD signaling in a mouse model of Alzheimer’s disease,and the potential neuroprotective effect.The results showed that the TβRII level was lower in APP/PS1 mouse hippocampus than in normal mouse hippocampus.After Dab2 expression,hippocampal TβRII and p-SMAD2/3 levels were significantly increased,while amyloid-beta deposition,microglia activation,tumor necrosis factor-βand interleulin-6 levels and neuronal loss were significantly attenuated in APP/PS1 mouse brain tissue.These results suggest that Dab2 can exhibit neuroprotective effects in Alzheimer’s disease by regulating TGF-β1/SMAD signaling. 关 键 词:转化生长因子-Β 小鼠模型 信号衰减 阿尔茨海默氏病 脑损伤 神经保护作用 TGF-β 肿瘤坏死因子-α
相关文献

参考文献(60)

引证文献(4)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费